The Specific Aims of this proposal are to elucidate the mechanism by which phenolic antioxidants and certain natural products; namely, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), 5,6-benzoflavone, and certain coumarin derivatives effectively inhibit monooxygenase activity in vitro and in vivo. These agents are known to be effective cancer chemoprevention agents and past work has indicated that they may exert their effect at the level of the cytochrome P-450-dependent monooxygenases required for metabolic activation of a number of carcinogens. Some evidence exists to indicate that certain metabolites of these cancer chemopreventive agents serve as redox-active agents which can prevent electron transfer to cytochrome P-450, but upon reduction by NADPH-cytochrome P-450 reductase can reduce molecular oxygen to hydrogen peroxide (i.e., stimulate NADPH oxidase activity). Standard chromatographic and analytical chemistry methods will be used to elucidate whether redox-active agents account for the action of these compounds or whether they directly interact with the monooxygenases. Integration of this information with the known biochemical mechanisms of the enzyme (heme reduction, oxygen activation, alteration of oxidase/oxygenase activity) will provide the conceptual framework for understanding their mechanism of action. For those compounds which inhibit monooxygenase activity, but do not stimulate the NADPH-oxidase activity of microsomes, we will establish how they affect the biochemical mechanism of cytochrome P-450. Subsequently, assays for monooxygenase function with carcinogens (metabolism, DNA or protein adduct formation, DNA damage) in the presence of these agents will be performed in more biologically integrated systems, such as isolated liver or lung cells to test the hypothesis of their mechanism of action. Such information may allow the design of therapeutic regimens to protect against the effects of many chemical carcinogens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA043839-02
Application #
3186225
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1986-03-01
Project End
1990-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Louisville
Department
Type
Schools of Arts and Sciences
DUNS #
City
Louisville
State
KY
Country
United States
Zip Code
40292
Singleton, D W; Lei, X D; Webb, S J et al. (1999) Cytochrome P-450 mRNAs are modulated by dehydroepiandrosterone, nafenopin, and triiodothyronine. Drug Metab Dispos 27:193-200
Lubet, R A; Gordon, G B; Prough, R A et al. (1998) Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations. Cancer Res 58:921-6
Song, W; Chen, J; Dean, W L et al. (1998) Purification and characterization of hamster liver microsomal 7alpha-hydroxycholesterol dehydrogenase. Similarity to type I 11beta-hydroxysteroid dehydrogenase. J Biol Chem 273:16223-8
Song, W; Pierce Jr, W M; Saeki, Y et al. (1996) Endogenous 7-oxocholesterol is an enzymatic product: characterization of 7 alpha-hydroxycholesterol dehydrogenase activity of hamster liver microsomes. Arch Biochem Biophys 328:272-82
Webb, S J; Xiao, G H; Geoghegan, T E et al. (1996) Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Mol Pharmacol 49:276-87
Prough, R A; Webb, S J; Wu, H Q et al. (1994) Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats. Cancer Res 54:2878-86
Gettings, S D; Brewer, C B; Pierce Jr, W M et al. (1990) Enhanced decomposition of oxyferrous cytochrome P450CIA1 (P450cam) by the chemopreventive agent 3-t-butyl-4-hydroxyanisole. Arch Biochem Biophys 276:500-9
Tweedie, D J; Prough, R A; Burke, M D (1988) Effects of induction on the metabolism and cytochrome P-450 binding of harman and other beta-carbolines. Xenobiotica 18:785-96
Tweedie, D J; Burke, M D (1987) Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites. Drug Metab Dispos 15:74-81